Cargando…

Rare disease education in Europe and beyond: time to act

People living with rare diseases (PLWRD) still face huge unmet needs, in part due to the fact that care systems are not sufficiently aligned with their needs and healthcare workforce (HWF) along their care pathways lacks competencies to efficiently tackle rare disease-specific challenges. Level of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tumiene, Birute, Peters, Harm, Melegh, Bela, Peterlin, Borut, Utkus, Algirdas, Fatkulina, Natalja, Pfliegler, György, Graessner, Holm, Hermanns, Sanja, Scarpa, Maurizio, Blay, Jean-Yves, Ashton, Sharon, McKay, Lucy, Baynam, Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761619/
https://www.ncbi.nlm.nih.gov/pubmed/36536417
http://dx.doi.org/10.1186/s13023-022-02527-y
_version_ 1784852715843616768
author Tumiene, Birute
Peters, Harm
Melegh, Bela
Peterlin, Borut
Utkus, Algirdas
Fatkulina, Natalja
Pfliegler, György
Graessner, Holm
Hermanns, Sanja
Scarpa, Maurizio
Blay, Jean-Yves
Ashton, Sharon
McKay, Lucy
Baynam, Gareth
author_facet Tumiene, Birute
Peters, Harm
Melegh, Bela
Peterlin, Borut
Utkus, Algirdas
Fatkulina, Natalja
Pfliegler, György
Graessner, Holm
Hermanns, Sanja
Scarpa, Maurizio
Blay, Jean-Yves
Ashton, Sharon
McKay, Lucy
Baynam, Gareth
author_sort Tumiene, Birute
collection PubMed
description People living with rare diseases (PLWRD) still face huge unmet needs, in part due to the fact that care systems are not sufficiently aligned with their needs and healthcare workforce (HWF) along their care pathways lacks competencies to efficiently tackle rare disease-specific challenges. Level of rare disease knowledge and awareness among the current and future HWF is insufficient. In recent years, many educational resources on rare diseases have been developed, however, awareness of these resources is still limited and rare disease education is still not sufficiently taken into account by some crucial stakeholders as academia and professional organizations. Therefore, there is a need to fundamentally rethink rare disease education and HWF development across the whole spectrum from students to generalists, specialists and experts, to engage and empower PLWRD, their families and advocates, and to work towards a common coherent and complementary strategy on rare disease education and training in Europe and beyond. Special consideration should be also given to the role of nurse coordinators in care coordination, interprofessional training for integrated multidisciplinary care, patient and family-centered education, opportunities given by digital learning and fostering of social accountability to enforce the focus on socially-vulnerable groups such as PLWRD. The strategy has to be developed and implemented by multiple rare disease education and training providers: universities, medical and nursing schools and their associations, professional organizations, European Reference Networks, patient organizations, other organizations and institutions dedicated to rare diseases and rare cancers, authorities and policy bodies.
format Online
Article
Text
id pubmed-9761619
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97616192022-12-19 Rare disease education in Europe and beyond: time to act Tumiene, Birute Peters, Harm Melegh, Bela Peterlin, Borut Utkus, Algirdas Fatkulina, Natalja Pfliegler, György Graessner, Holm Hermanns, Sanja Scarpa, Maurizio Blay, Jean-Yves Ashton, Sharon McKay, Lucy Baynam, Gareth Orphanet J Rare Dis Position Statement People living with rare diseases (PLWRD) still face huge unmet needs, in part due to the fact that care systems are not sufficiently aligned with their needs and healthcare workforce (HWF) along their care pathways lacks competencies to efficiently tackle rare disease-specific challenges. Level of rare disease knowledge and awareness among the current and future HWF is insufficient. In recent years, many educational resources on rare diseases have been developed, however, awareness of these resources is still limited and rare disease education is still not sufficiently taken into account by some crucial stakeholders as academia and professional organizations. Therefore, there is a need to fundamentally rethink rare disease education and HWF development across the whole spectrum from students to generalists, specialists and experts, to engage and empower PLWRD, their families and advocates, and to work towards a common coherent and complementary strategy on rare disease education and training in Europe and beyond. Special consideration should be also given to the role of nurse coordinators in care coordination, interprofessional training for integrated multidisciplinary care, patient and family-centered education, opportunities given by digital learning and fostering of social accountability to enforce the focus on socially-vulnerable groups such as PLWRD. The strategy has to be developed and implemented by multiple rare disease education and training providers: universities, medical and nursing schools and their associations, professional organizations, European Reference Networks, patient organizations, other organizations and institutions dedicated to rare diseases and rare cancers, authorities and policy bodies. BioMed Central 2022-12-19 /pmc/articles/PMC9761619/ /pubmed/36536417 http://dx.doi.org/10.1186/s13023-022-02527-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Position Statement
Tumiene, Birute
Peters, Harm
Melegh, Bela
Peterlin, Borut
Utkus, Algirdas
Fatkulina, Natalja
Pfliegler, György
Graessner, Holm
Hermanns, Sanja
Scarpa, Maurizio
Blay, Jean-Yves
Ashton, Sharon
McKay, Lucy
Baynam, Gareth
Rare disease education in Europe and beyond: time to act
title Rare disease education in Europe and beyond: time to act
title_full Rare disease education in Europe and beyond: time to act
title_fullStr Rare disease education in Europe and beyond: time to act
title_full_unstemmed Rare disease education in Europe and beyond: time to act
title_short Rare disease education in Europe and beyond: time to act
title_sort rare disease education in europe and beyond: time to act
topic Position Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761619/
https://www.ncbi.nlm.nih.gov/pubmed/36536417
http://dx.doi.org/10.1186/s13023-022-02527-y
work_keys_str_mv AT tumienebirute rarediseaseeducationineuropeandbeyondtimetoact
AT petersharm rarediseaseeducationineuropeandbeyondtimetoact
AT meleghbela rarediseaseeducationineuropeandbeyondtimetoact
AT peterlinborut rarediseaseeducationineuropeandbeyondtimetoact
AT utkusalgirdas rarediseaseeducationineuropeandbeyondtimetoact
AT fatkulinanatalja rarediseaseeducationineuropeandbeyondtimetoact
AT pflieglergyorgy rarediseaseeducationineuropeandbeyondtimetoact
AT graessnerholm rarediseaseeducationineuropeandbeyondtimetoact
AT hermannssanja rarediseaseeducationineuropeandbeyondtimetoact
AT scarpamaurizio rarediseaseeducationineuropeandbeyondtimetoact
AT blayjeanyves rarediseaseeducationineuropeandbeyondtimetoact
AT ashtonsharon rarediseaseeducationineuropeandbeyondtimetoact
AT mckaylucy rarediseaseeducationineuropeandbeyondtimetoact
AT baynamgareth rarediseaseeducationineuropeandbeyondtimetoact